Pharmacological inhibition of CDK7 by THZ1 impairs tumor growth in p53‐mutated HNSCC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacological inhibition of CDK7 by THZ1 impairs tumor growth in p53‐mutated HNSCC

Published:2021-02-06 Issue: Volume: Page:
ISSN:1354-523X
Container-title:Oral Diseases
language:en
Short-container-title:Oral Dis

Author:

Ge Han¹²,Yao Yuan¹²,Jiang Yue¹²,Wu Xiang¹³,Wang Yanling¹²^ORCID

Affiliation:

1. Jiangsu Key Laboratory of Oral Disease Nanjing Medical University Jiangsu China PRC

2. Department of Oral and Maxillofacial Surgery Affiliated Hospital of Stomatology Nanjing Medical University Nanjing China PRC

3. Department of Oral Pathology Affiliated Hospital of Stomatology Nanjing Medical University Nanjing China PRC

Funder

National Natural Science Foundation of China-Guangdong Joint Fund

Priority Academic Program Development of Jiangsu Higher Education Institutions

Jiangsu Provincial Key Research and Development Program

Publisher

Wiley

Subject

General Dentistry,Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/odi.13783

Reference32 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review

3. Comprehensive genomic characterization of head and neck squamous cell carcinomas

4. Inhibit Globally, Act Locally: CDK7 Inhibitors in Cancer Therapy

5. Oral cavity and oropharyngeal squamous cell carcinoma-an update

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax;Journal of Experimental & Clinical Cancer Research;2023-07-29

2. Targeting the Heterogeneous Genomic Landscape in Triple-Negative Breast Cancer through Inhibitors of the Transcriptional Machinery;Cancers;2022-09-07

3. CDK7 Predicts Worse Outcome in Head and Neck Squamous-Cell Cancer;Cancers;2022-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3